These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 1850043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD.
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
    Li J, Zhang LB, Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Hara M, Nomura T, Yoshikura H, Miyamura T, Hagiwara A.
    Arch Virol; 1996 Jan; 141(6):1047-54. PubMed ID: 8712922
    [Abstract] [Full Text] [Related]

  • 5. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R.
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [Abstract] [Full Text] [Related]

  • 6. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV, Fan L, Asher DM, Fibi MR, Dragunsky EM, Chumakov KM.
    Virology; 1999 May 25; 258(1):152-60. PubMed ID: 10329577
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
    Westrop GD, Wareham KA, Evans DM, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Skinner MA, Schild GC.
    J Virol; 1989 Mar 25; 63(3):1338-44. PubMed ID: 2536836
    [Abstract] [Full Text] [Related]

  • 9. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F, Da-Silva EF, Schatzmayr HG.
    Acta Virol; 1996 Feb 25; 40(1):27-33. PubMed ID: 8886095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
    Blomqvist S, Bruu AL, Stenvik M, Hovi T.
    J Gen Virol; 2003 Mar 25; 84(Pt 3):573-580. PubMed ID: 12604808
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.
    Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F.
    J Virol; 1993 Aug 25; 67(8):4630-8. PubMed ID: 8392604
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A, Markoulatos P.
    Eur J Clin Microbiol Infect Dis; 2001 Nov 25; 20(11):792-9. PubMed ID: 11783695
    [Abstract] [Full Text] [Related]

  • 20. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M, Chang S, Iber J, Zhao K, Adeniji JA, Bukbuk D, Baba M, Behrend M, Burns CC, Oberste MS.
    J Virol; 2016 Jan 01; 90(1):317-31. PubMed ID: 26468545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.